The Head of Market Access Australia and New Zealand (ANZ) develops, leads and executes market access strategies for Biogen brands. This role is responsible for patients’ access to Biogen current and future products in Australia and New Zealand by securing timely access and optimal pricing including reimbursement for new and existing products aligning with Global and Local strategic objectives. They will ensure the access team is fit for the future, addressing both Government reimbursement, companion diagnostics, pricing strategies and innovate funding pathways across the product lifecycle.
Being responsible for the leadership and management of the market access function of the Australia and New Zealand Affiliate (ANZ), the Head of Market Access ensures full strategic, tactical and operational responsibility for their department.
This individual maintains a broad knowledge of access related policy and pricing issues that occur within the therapeutic areas, as well as issues that affect the pricing and access of pharmaceutical products in Australia and New Zealand. Working collaboratively with the Head of External Affairs and Policy, they play a critical role in developing and driving and shaping Biogen and the industry policy position as it relates to access to medicines. They initiate and lead interactions with key external stakeholders including the PBAC, PHARMAC, MSAC, representatives of the Departments of Health in Australia and New Zealand, Medicines Australia, Medicines New Zealand and other stakeholders in the reimbursement process.
Reporting to the ANZ Managing Director, this position will build and lead a team of Market Access professionals by inspiring and motivating the team, in addition to being a positive change agent who pro-actively disseminates appropriate information to key stakeholders.
The role sits on the ANZ affiliate leadership team and guides decision making on pan-affiliate matters such as policies, culture and training needs.
Accountabilities:
Strategy development and implementation /operational excellence (40%)
Scope:
Requirements:
Job Level: Management
We are a global team with a commitment to excellence, and a pioneering spirit. As a mid-sized biotechnology company, we provide the stability and resources of a well-established business while fostering an environment where individual contributions make a significant impact. Our team encompasses some of the most talented and passionate achievers who have unparalleled opportunities for learning, growth, and expanding their skills. Above all, we work together to deliver life-changing medicines, with every role playing a vital part in our mission. Caring Deeply. Achieving Excellence. Changing Lives.
At Biogen, we are committed to building on our culture of inclusion and belonging that reflects the communities where we operate and the patients we serve. We know that diverse backgrounds, cultures, and perspectives make us a stronger and more innovative company, and we are focused on building teams where every employee feels empowered and inspired. Read onto learn more about our DE&I efforts.
All qualified applicants will receive consideration for employment without regard to sex, gender identity or expression, sexual orientation, marital status, race, color, national origin, ancestry, ethnicity, religion, age, veteran status, disability, genetic information or any other basis protected by federal, state or local law. Biogen is an E-Verify Employer in the United States.

Founded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patients’ lives and to create value for shareholders and our communities.
We apply deep understanding of human biology and leverage different modalities, to advance first-in-class treatments or therapies that deliver superior outcomes. Our approach is to take bold risks, balanced with return on investment to deliver long-term growth.
With approximately 7,000 people worldwide, we are truly a global organization, headquartered in Cambridge, Massachusetts, which is also home to our research operations. Our international headquarters are based in Baar, Switzerland and we have world-class manufacturing facilities in North Carolina and Solothurn, Switzerland. We offer therapies globally through direct affiliate presence in 30 countries and a network of distribution partners in over 50 additional countries.
For more information, please visit www.biogen.com. Community Guidelines: https://www.biogen.com/community-guidelines.html
Follow us on social media – LinkedIn, Facebook, X, and YouTube.